8/26/2013

Francis Reynolds has stepped down as CEO and chief financial officer of InVivo Therapeutics. The company has appointed Michael Astrue, board chairman at Vivus, to be its CEO on an interim basis and Sean Moran, InVivo's finance director, to serve as acting CFO.

Related Summaries